 |
 |
GSK, MD Anderson Cancer Center to develop new cancer drugs
10 December 2012
|
|
|
|
GSK Consumer Healthcare share buyback opens on 17 January
05 December 2012
|
|
|
Glaxo makes open offer to hike stake in Indian arm
26 November 2012
|
| | |
|
|
GSK to sell Australian generic portfolio to Aspen Pharma
16 August 2012
|
|
|
Human Genome Sciences agrees to GSK's revised $3-bn offer
17 July 2012
|
|
|
GSK to close Human Genome Sciences acquisition with $2.8-bn revised offer: report
16 July 2012
|
|
|
GlaxoSmithKline to pay record $3 billion in US drug fraud case
03 July 2012
|
|
|
GSK to buy new eczema drug Toctino from Basilea Pharmaceutica for £146 mn
12 June 2012
|
|
|
GlaxoSmithKline extends $2.6 billion offer for Human Genome Sciences
09 June 2012
|
|
|
Human Genome adopts poison pill to thwart $2.6-bn hostile GSK bid
18 May 2012
|
|
|
GlaxoSmithKline goes hostile with its $2.59-bn bid for Human Genome Sciences
09 May 2012
|
|
|
Aspen to buy GSK’s international OTC brands
20 April 2012
|
|
|
GlaxoSmithKline’s $2.6-bn bid rejected by Human Genome Sciences
19 April 2012
|
|
|
GSK to sell most European OTC drugs to Omega Pharma
15 March 2012
|
|
|
GlaxoSmithKline end-quarter 2011 net rises over 18 per cent to Rs137 crore
16 February 2012
|
|
|
GSK repatriating funds daily from European operations
08 February 2012
|
|
|
GSK to sell some North American OTC drugs to Prestige Brands for $661 mn
21 December 2011
|
|
|
GSK to pay $3 bn to settle US investigations for promoting drugs for unapproved uses
03 November 2011
|
|
|
Patented drugs overpriced, admits Glaxo CEO Witty
28 September 2011
|
|
|
GSK to pay $40.75 mn to 37 US states to settle sub-standard manufacturing lawsuit
24 June 2011
|
|
|
GlaxoSmithKline loses appeal in Rs71.21-crore Drug Price Equalisation Account demand
13 April 2011
|
|
|
GlaxoSmithKline to take $3.4-bn legal charge for diabetes drug Avandia
18 January 2011
|
|
|
GlaxoSmithKline acquires rights to Parkinson’s drug from Impax
16 December 2010
|
|
|
Glaxo to buy China's specialist drugmaker MeiRui Pharma for $70 million
08 December 2010
|
|
|
GlaxoSmithKline plans to acquire China’s Nanjing MeiRui Pharma
02 December 2010
|
|
|
GSK plans to invest £500 million in new projects in UK
01 December 2010
|
|
|
GlaxoSmithKline expands research collaboration with Brazil's Fiocruz
13 November 2010
|
|
|
GlaxoSmithKline to pay $750 mn to settle US adulterated drugs lawsuit
27 October 2010
|
|
|
Regulators in EU, US "kill" Glaxo’s diabetes drug Avandia
24 September 2010
|
|
|
GSK sues Roche over Genentech's cancer drug patent infringement
23 September 2010
|
|
|
UK regulator moots withdrawing GSK’s Avandia drug from UK market
06 September 2010
|
|
|
GSK investigates Pandermix link to chronic sleep disorder
04 September 2010
|
|
|
Glaxo follows Sanofi-Aventis to biotech major Genzyme
26 July 2010
|
|
|
GlaxoSmithKline net sales up 9 per cent
26 July 2010
|
|
|
FDA wants GSK to add more health warnings on diabetese drug Avandia
15 July 2010
|
|
|
GlaxoSmithKline: truth is a bitter pill
14 July 2010
|
|
|
Hyderabad-based Aptuit Laurus's parent to acquire GSK's Verona research operations
02 July 2010
|
|
|
GlaxoSmithKline acquires Argentina’s Laboratorios Phoenix for $253 million
11 June 2010
|
|
|
GSK acquires 9.9-per cent stake in S Korea's top phrma firm, Dong-A
12 May 2010
|
|
|
GSK Q1 earnings surge on swine flue vaccine
29 April 2010
|
|
|
GSK, Isis Pharma in RNA therapeutics licencing pact
31 March 2010
|
|
|
GlaxoSmithKline on the prowl for acquisitions in India
09 March 2010
|
|
|
GlaxoSmithKline forced to remove zinc from denture cream products
22 February 2010
|
|
|
GSK Pharma posts Q4 PAT of Rs103.59 crore
16 February 2010
|
|
|
GlaxoSmithKline keeps jobs as 2009 profit jump 12 per cent to £8.73 billion
05 February 2010
|
|
|
GlaxoSmithKline inks up to $330 million drug deal with Apeiron Biologics
03 February 2010
|
|
|
GlaxoSmithKline may follow AstraZeneca in axing jobs: report
01 February 2010
|
|
|
GSK inching closer to deal with Dr Reddy's?
08 January 2010
|
|
|
DCGI asks GSK to withdraw promotional campaign
26 December 2009
|
|
|
GSK and Intercell to develop innovative needle-free patch-based vaccines
12 December 2009
|
|
|
GlaxoSmithkline suspends operations at Andhra unit
11 December 2009
|
|
|
Glaxo targets emerging markets for acquisitions, tie-ups
11 December 2009
|
|
|
GSK receives orders for 440 million doses of H1N1 vaccine
06 October 2009
|
|
|
Glaxo seeking stake in Dr Reddy’s: report
18 September 2009
|
|
|
GSK to test swine flu vaccine in India at selected sites
03 September 2009
|
|
|
Glenmark faces GSK patent challenge in US over malaria drug
18 August 2009
|
|
|
GlaxoSmithKline retains Mahindra Satyam for IT deal
10 July 2009
|
|
|
GSK signs drug pact with Chroma Therapeutics
24 June 2009
|
|
|
Glaxo ties up with Dr Reddy's for emerging markets
15 June 2009
|
|
|
GSK in new venture pact with Shenzhen Neptunus to make influenza vaccines in China
09 June 2009
|
|
|
GSK close to acquiring Stiefel Lab for $3 billion
20 April 2009
|
|
|
GSK, Pfizer to merge HIV businesses into a new company
17 April 2009
|
|
|
Glaxo, Sanofi in talks for Shanta Biotch takeover
30 March 2009
|
|
|
GSK eyes push into emerging markets through Asken buy
28 March 2009
|
|
|
J&J, GSK, Novartis eye world's top dermatologist Stiefel
21 March 2009
|
|
|
Wockhardt to launch ulcer drug Ranitidine in the US
26 February 2009
|
|
|
Glaxo buys UCB patents
24 January 2009
|
|
|
GlaxoSmithKline acquires Bristol-Myers Squibb Pakistan
22 December 2008
|
|
|
GSK to focus on modern retail trade
31 October 2008
|
|
|
Horlicks may make Indian kids ‘taller, stronger, sharper’, but not in the UK
24 October 2008
|
|
|
Glaxo acquires oral care product Biotene for $170 million
22 October 2008
|
|
|
Ranbaxy-GSK submits IND application for respiratory inflammation candidate
13 October 2008
|
|
|
Kids channel Nick to go blank on 27 September to promote ‘Let’s Just Play’ initiative
01 September 2008
|
|
|
GlaxoSmithKline teams up with South Africa's Aspen to market branded generics
23 July 2008
|
|
|
Exelixis and GlaxoSmithKline to conclude six-year discovery and development collaboration
28 June 2008
|
|
|
Glaxo to cut 350 R&D jobs in drug research revamp
11 June 2008
|
|
|
GlaxoSmithKline, Daiichi in hypertension drug deal in India
14 May 2008
|
|
|
GSK Pharma signs licensing agreement with Astellas of Japan
05 May 2008
|
|
|
GlaxoSmithKline acquires Sirtris Pharmaceuticals
24 April 2008
|
|
|
US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales
06 February 2008
|
|
|
Women’s Horlicks from GSK Consumer
30 January 2008
|
|
|
Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline
21 January 2008
|
|
|
GSK to launch cancer drug Tykerb in India
10 November 2007
|
|
|
Ranbaxy, GSK to settle valacyclovir patent case in US
26 July 2007
|
|
|
GlaxoSmithKline pharmaceuticals
divests fine
26 July 2007
|
|
|
Ranbaxy-GSK
alliance to develop respiratory drug
02 April 2007
|
|
|
Ranbaxy-Glaxo
extend pact
07 February 2007
|
|
|
Glaxo
moves court against Ranbaxy''s generic drug
03 February 2007
|
|
|
Glaxo buys Genmab's leukemia drug for record $2.1 billion
19 December 2006
|
|
|
Dr Reddy's to get generic rights as Glaxo settles Imitrex patent row
10 October 2006
|
|
|
GSK
withdraws patent plea for AIDS drug Combivir
21 August 2006
|
|
|
GlaxoSmithKline
Q2 net falls 12 per cent
27 July 2006
|
|
|
Ranbaxy acquires GlaxoSmithKline subsidiary Mundogen in Spain
18 July 2006
|
|
|
Ranbaxy to acquire Glaxo's generic business in Italy
28 March 2006
|
|
|
Oxford,
GSK to partner in cancer research at leading clinical
centres In India
17 October 2005
|
|
|
GSK makes a ''horlicks''
out its media meet
17 June 2005
|
|
|
GSK
India announces buyback
15 March 2005
|
|
|
On the clinical trial trail
11 March 2005
|
|
|
GlaxoSmithKline to locate first Indian vaccine plant at Nashik
23 February 2005
|
|
|
GlaxoSmithKline Q4-05 up at 61.4%
17 February 2005
|
|
|
GSK
sells worli plot for Rs107.6 crores
24 April 2004
|
|
|
GlaxoSmithKline, Burroughs Wellcome boards approve merger
18 March 2004
|
|
|
Horlicks
gets new flavours
10 July 2003
|
|
|
GlaxoSmithKline
announces a dividend of Rs 7 per equity share
13 March 2003
|
|
|
GlaxoSmithKline declares second interim dividend of 37%
21 December 2002
|
|
|
Glaxo
SmithKline defers merger with Burroughs Wellcome
09 December 2002
|
|
|
Ranbaxy
refutes Glaxo’s
charge of stealing
24 August 2002
|
|
|
Glaxo
SmithKline to sue
Novartis, Ranbaxy
23 August 2002
|
|
|
GlaxoSmithKline
interim dividend at 33%
31 July 2002
|
|
|
GlaxoSmithkline
to launch new products
12 March 2002
|
|
|
Pharma sector fared well in 2001
28 December 2001
|
|
|
Pharma
companies in talks with MIDC
13 December 2001
|
|
|
Iodex goes
to SmithKline Healthcare
26 November 2001
|
|
|
GlaxoSmithKline''s plans for
Affymax runs aground
31 July 2001
|
|
|
GlaxoSmithKline to sell-off
Affymax
21 March 2001
|
|
|
GlaxoSmithKline strikes
licensing deal with Merck
16 February 2001
|
|
|
Glaxo Wellcome,
SmithKline Beecham agree to merge
17 January 2000
|
|
|
Large
market share
17 January 2000
|
|
|
Why
the merger worked this time
17 January 2000
|
